KYNTRA BIO, INC. (KYNB) — Institutional Holders, Q2 2026
27 institutional investment managers reported a KYNB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $7.5M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
KYNB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- GSA CAPITAL PARTNERS LLPNew · +15,697 sh+$118.5K
- VANGUARD CAPITAL MANAGEMENTAdded · +3,343 sh+$25.2K
- Tower Research Capital (TRC)Added · +781 sh+$5.9K
- VANGUARD FIDUCIARYAdded · +163 sh+$1.2K
- HighTower AdvisorsAdded · +2 sh+$15.00
Biggest sellers
- UBS Group AGTrimmed · -19,734 sh-$149.0K
- JANE STREET GROUPSold out · -12,228 sh-$92.3K
- ADAR1 Capital ManagementSold out · -10,469 sh-$79.0K
- TWO SIGMA INVESTMENTSTrimmed · -10,000 sh-$75.5K
- GEODE CAPITAL MANAGEMENTTrimmed · -2,779 sh-$21.0K
KYNB 13F holders ranked 1–27 of 27
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL#1 · 400,000 sh | 400,000 | $3.0M | 0.04% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 159,950 sh | 159,950 | $1.2M | 0.00% | +2.1% |
| 3 | ACADIAN ASSET MANAGEMENT#3 · 105,585 sh | 105,585 | $795.0K | <0.01% | 0.0% |
| 4 | BlackRock#4 · 84,330 sh | 84,330 | $636.7K | 0.00% | 0.0% |
| 5 | GEODE CAPITAL MANAGEMENT#5 · 43,219 sh | 43,219 | $326.4K | 0.00% | -6.0% |
| 6 | HighTower Advisors#6 · 39,746 sh | 39,746 | $300.1K | <0.01% | 0.0% |
| 7 | TWO SIGMA INVESTMENTS#7 · 39,511 sh | 39,511 | $298.3K | <0.01% | -20.2% |
| 8 | RENAISSANCE TECHNOLOGIES#8 · 27,081 sh | 27,081 | $204.5K | <0.01% | -1.5% |
| 9 | VANGUARD FIDUCIARY#9 · 24,105 sh | 24,105 | $182.0K | 0.00% | +0.7% |
| 10 | Birchview Capital#10 · 22,566 sh | 22,566 | $170.4K | 0.08% | 0.0% |
| 11 | STATE STREET#11 · 20,284 sh | 20,284 | $153.1K | 0.00% | 0.0% |
| 12 | GSA CAPITAL PARTNERS LLP#12 · 15,697 sh | 15,697 | $119.0K | <0.01% | New |
| 13 | UBS Group AG#13 · 7,857 sh | 7,857 | $59.3K | 0.00% | -71.5% |
| 14 | GROUP ONE TRADING, L.P.#14 · 4,406 sh | 4,406 | $33.3K | 0.00% | -1.9% |
| 15 | Vanguard Global Advisers#15 · 1,424 sh | 1,424 | $10.8K | 0.00% | 0.0% |
| 16 | Tower Research Capital (TRC)#16 · 1,113 sh | 1,113 | $8.4K | <0.01% | +235.2% |
| 17 | Axiom Investment Management#17 · 704 sh | 704 | $5.3K | <0.01% | 0.0% |
| 18 | MORGAN STANLEY#18 · 487 sh | 487 | $3.7K | 0.00% | -0.2% |
| 19 | HARBOUR INVESTMENTS#19 · 200 sh | 200 | $1.5K | 0.00% | 0.0% |
| 20 | NATIONAL BANK OF CANADA#20 · 193 sh | 193 | $1.4K | 0.00% | 0.0% |
| 21 | OSAIC#21 · 182 sh | 182 | $1.4K | 0.00% | +1.1% |
| 22 | SBI Securities , Ltd.#22 · 152 sh | 152 | $1.1K | — | 0.0% |
| 23 | ROYAL BANK OF CANADA#23 · 138 sh | 138 | $1.0K | 0.00% | +0.7% |
| 24 | BNP PARIBAS FINANCIAL MARKETS#24 · 46 sh | 46 | $347.00 | 0.00% | -8.0% |
| 25 | JPMORGAN CHASE#25 · 12 sh | 12 | $88.00 | 0.00% | 0.0% |
| 26 | DANSKE BANK A/S#26 · 1 sh | 1 | $8.00 | 0.00% | 0.0% |
| 27 | Smithfield#27 · 1 sh | 1 | $0.00 | 0.00% | 0.0% |
Funds that sold out of KYNB in Q2 2026 (5)
Held KYNB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| JANE STREET GROUP12,228 sh | 12,228 | $82.9K |
| ADAR1 Capital Management10,469 sh | 10,469 | $71.0K |
| CFG Wealth Management Services3 sh | 3 | $20.00 |
| US BANCORP \DE\1 sh | 1 | $7.00 |
| CITIGROUP1 sh | 1 | $7.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.